ALEXANDRIA, Va., June 17 -- United States Patent no. 12,310,982, issued on May 27.
"Use of the poloxamer as a pharmacologically active substance" was invented by Elena Valentinovna Arshintseva (Saransk, Russia) and Sergei Yurevich Pushkin (Noginsk, Russia).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the field of medicine and veterinary medicine, in particular to a new use of the poloxamer as a pharmacologically active substance A new use of the poloxamer as a pharmacologically active substance to increase the levels of haemoglobin and red blood cells in a patients blood is revealed. Thus, new pharmacologically active substances that promote a rise in haemoglobin and red blood cell ...